Literature DB >> 7510238

Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases.

T Morio1, R S Geha, T A Chatila.   

Abstract

Staphylococcal exotoxins (SE) are superantigens that bind to monomorphic determinants on major histocompatibility complex (MHC) class II molecules and stimulate human peripheral blood T lymphocytes in a V beta-specific manner. SE also deliver activation signals via MHC class II molecules that initiate cell adhesion and cytokine gene transcription. These events are preceded by tyrosine phosphorylation and are antagonized by inhibitors of tyrosine kinases, indicating an essential role for these kinases in signaling via class II molecules. We report that stimulation of human peripheral blood monocytes with SE induced rapid and selective activation of the src-related protein tyrosine kinases (PTK) fgr and hck. SE also induced the activation of fgr and lyn in B cells. PTK activation by SE required MHC class II expression, and was greatly potentiated in the presence of T cells bearing toxin-specific V beta chains. These results indicate that in addition to their antigen and superantigen-presenting function, MHC class II molecules act as signal-transducing receptors that are coupled to src-type PTK.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510238     DOI: 10.1002/eji.1830240325

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

Review 2.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

3.  Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.

Authors:  W A Nockher; J E Scherberich
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 4.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

5.  Production of tumor necrosis factor alpha in human T lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C.

Authors:  Z Yan; D C Yang; R Neill; M Jett
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1.

Authors:  V Aubert; D Schneeberger; A Sauty; J Winter; P Sperisen; J D Aubert; F Spertini
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Characterization of a 23-kDa protein associated with CD40.

Authors:  T Morio; S Hanissian; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 9.  B cell MHC class II signaling: A story of life and death.

Authors:  Divya Sai Katikaneni; Lei Jin
Journal:  Hum Immunol       Date:  2018-04-30       Impact factor: 2.850

10.  CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.

Authors:  M T Zilber; S Gregory; R Mallone; S Deaglio; F Malavasi; D Charron; C Gelin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.